Yuanhua Pharmaceuticals (002262.SZ) plans to invest 20 million yuan to participate in a pharmaceutical industry investment fund.

Zhixin Finance and Economics APP News, Enhua Pharmaceutical (002262.SZ) announced that the company, along with Shanghai DeFuFuChuang Consultancy Management Limited Partnership (hereinafter referred to as "Shanghai DeFuFu") and other partners, jointly initiated the establishment of Shanghai DeFuFu Entrepreneurial Investment Fund Limited Partnership (tentatively named) (subject to the name registered by the market supervision department, hereinafter referred to as "DeFu Fund" or "partnership"), and signed the "Shanghai DeFuFu Entrepreneurial Investment Fund Limited Partnership Agreement". The target subscription size of DeFu Fund is RMB 800 million, with the company as a limited partner contributing RMB 20 million of its own funds, representing an expected 2.50% of the target subscription size of the partnership. The partnership will primarily invest in companies in the fields of innovative pharmaceuticals and biotechnology, innovative equipment, high-end life science instruments and equipment, medical artificial intelligence, and other sectors.